KRAS and colorectal carcinoma: BaP1 activity and selectivity were investigated using the noncancerous colon cell line NCM460 and CRC-derived cell lines harboring somatic mutations on KRAS or BRAF, SW480 (KRASG12V), HCT116 (KRASG13D), and RKO (BRAFV600E).